Search results for: 'agent more'

23 Dec 2020  |  North America  |  Market Research

Growth Opportunity Analysis of the North American Clinical Documentation Improvement (CDI) Market

Internal Challenges, Disruptive Technologies, and Competitive Intensity are Driving CDI to become a More Value-based Process

Infographics

×

This Frost & Sullivan research service presents a comprehensive overview of the North American clinical documentation improvement (CDI) market. CDI is a mid-process in the broader revenue cycle management (RCM) ecosystem. This study analyzes key product segments, major end users, and top vendors across the United States and Canada. Revenue is fo...

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

26 Feb 2020  |  Europe  |  Market Research

Growth Opportunities from the Evolution of Electronic Health Record (EHR) in Europe, Forecast to 2024

Actionable Strategies and Tactics to Accelerate Growth in a Transforming Market

Infographics

×

The healthcare IT landscape is witnessing rapid transformation as governments focus more on value-based care and preventive health programs to reduce the overall economic burden on health systems, along with increased efficiency in managing increasing patient populations. The basic Electronic Medical Record (EMR) is evolving into a more comprehensi...

17 Nov 2020  |  North America  |  Market Research

Business Models Focusing on Patient Centricity Driving Incremental Value in the Global Digital Patient Engagement Solutions Market, 2025

Growth Strategies to Revolve Around Value-based Care and Population Health Management Initiatives

Infographics

×

Healthcare is evolving, more so after the Coronavirus 2019 (COVID-19) pandemic that hit us in the beginning of 2020. Over time, we have seen surveys that indicate that patients want more control of their healthcare and be active participants of their treatment decisions. Innovations in technology and recent developments in the healthcare ecosystem ...

Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...

23 Dec 2020  |  North America  |  Frost Radar

Frost Radar™: US Healthcare Cybersecurity Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

The US healthcare cybersecurity market is poised for aggressive growth after the COVID-19 pandemic ends. The impending challenges related to the top 5 cyber threats (phishing attacks, credential harvesting, ransomware, social engineering attacks, and information theft or loss) will drive a higher spend on progressive cybersecurity solutions across...

05 Aug 2020  |  North America  |  Frost Radar

Frost Radar™: Medical Devices in Atrial Fibrillation Market, 2020

Benchmarking Future Growth Potential

Infographics

×

This Frost Radar™ analyzes emerging trends in the atrial fibrillation (AFib) landscape and profiles key market participants that deliver innovative solutions and maintain leadership in major segments in the care continuum, such as screening and monitoring, image-guided navigation and cardiac mapping, cardiac ablation, and left atrial appendage (LAA...

27 Jan 2020  |  Global  |  Market Research

Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022

Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth

Infographics

×

Key Issues Addressed

The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...